Fuminori Yoshida
Founder bij SYMBIO PHARMACEUTICALS LIMITED
Vermogen: 1 M $ op 31-03-2024
Actieve functies van Fuminori Yoshida
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SYMBIO PHARMACEUTICALS LIMITED | Director/Board Member | 25-03-2005 | - |
Chief Executive Officer | 25-03-2005 | - | |
Founder | 25-03-2005 | - | |
President | 25-03-2005 | - |
Loopbaan van Fuminori Yoshida
Eerdere bekende functies van Fuminori Yoshida
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Syntex Japan Co., Ltd. | Corporate Officer/Principal | 01-01-1993 | 15-09-2009 |
President | 15-09-2009 | - | |
AHS Japan, Inc. | Corporate Officer/Principal | - | - |
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Founder | 01-01-1993 | - |
President | 01-01-1993 | - | |
MITSUBISHI CORPORATION | Corporate Officer/Principal | - | - |
Nippon Bio-Rad Laboratories | Founder | 03-08-2009 | - |
President | 03-08-2009 | - |
Opleiding van Fuminori Yoshida
Harvard University | Graduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Gakushuin University | Undergraduate Degree |
Statistieken
Internationaal
Japan | 8 |
Verenigde Staten | 3 |
Operationeel
President | 4 |
Founder | 3 |
Corporate Officer/Principal | 3 |
Sectoraal
Consumer Services | 3 |
Health Technology | 3 |
Distribution Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MITSUBISHI CORPORATION | Distribution Services |
SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Amgen KK
Amgen KK Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Amgen KK is a wholly owned Japanese affiliate of Amgen Inc., one of the largest independent biotechnology companies in the world. The private company is based in Tokyo, Japan. Amgen KK focuses on disease areas with significant unmet medical needs, including cardiometabolic, oncological, bone, inflammation/immune and neurological diseases. Currently, approximately 600 employees engage in activities from clinical development to sales with the mission of "to serve patients – doing everything we can now, for the patients." The Japanese company was founded by Fuminori Yoshida. Amgen KK was acquired by Takeda Pharmaceutical Co., Ltd. from Amgen, Inc. on March 31, 2008 for $16.58 million. | Health Technology |
Nippon Bio-Rad Laboratories | |
AHS Japan, Inc. | |
Syntex Japan Co., Ltd. |
- Beurs
- Insiders
- Fuminori Yoshida
- Ervaring